Daewoong Pharma
KRX:069620

Watchlist Manager

Daewoong Pharma

KRX:069620

Watchlist

Dividends

Discount Rate

Price: 138 700 KRW -0.93% Market Closed

Market Cap: 1.6T KRW

Have any thoughts about
Daewoong Pharma?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 138700 KRW

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

Alert

Daewoong Pharma

138700

-1300 (-0.93%)

52 Week Range	99 900 150 000
Price Target

We'll email you a reminder when the closing price reaches KRW.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Daewoong Pharma

What unique competitive advantages
does Daewoong Pharma hold over its rivals?

What risks and challenges
does Daewoong Pharma face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Daewoong Pharma.

What unique competitive advantages
does Daewoong Pharma hold over its rivals?

What risks and challenges
does Daewoong Pharma face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Daewoong Pharma.

Provide P/S
for Daewoong Pharma.

Provide P/E
for Daewoong Pharma.

Provide P/OCF
for Daewoong Pharma.

Provide P/FCFE
for Daewoong Pharma.

Provide P/B
for Daewoong Pharma.

Provide EV/S
for Daewoong Pharma.

Provide EV/GP
for Daewoong Pharma.

Provide EV/EBITDA
for Daewoong Pharma.

Provide EV/EBIT
for Daewoong Pharma.

Provide EV/OCF
for Daewoong Pharma.

Provide EV/FCFF
for Daewoong Pharma.

Provide EV/IC
for Daewoong Pharma.

Show me price targets
for Daewoong Pharma made by professional analysts.

What are the Revenue projections
for Daewoong Pharma?

How accurate were the past Revenue estimates
for Daewoong Pharma?

What are the Net Income projections
for Daewoong Pharma?

How accurate were the past Net Income estimates
for Daewoong Pharma?

What are the EPS projections
for Daewoong Pharma?

How accurate were the past EPS estimates
for Daewoong Pharma?

What are the EBIT projections
for Daewoong Pharma?

How accurate were the past EBIT estimates
for Daewoong Pharma?

Compare the revenue forecasts
for Daewoong Pharma with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Daewoong Pharma and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Daewoong Pharma against its competitors.

Analyze the profit margins
(gross, operating, and net) of Daewoong Pharma compared to its peers.

Compare the P/E ratios
of Daewoong Pharma against its peers.

Discuss the investment returns and shareholder value creation
comparing Daewoong Pharma with its peers.

Analyze the financial leverage
of Daewoong Pharma compared to its main competitors.

Show all profitability ratios
for Daewoong Pharma.

Provide ROE
for Daewoong Pharma.

Provide ROA
for Daewoong Pharma.

Provide ROIC
for Daewoong Pharma.

Provide ROCE
for Daewoong Pharma.

Provide Gross Margin
for Daewoong Pharma.

Provide Operating Margin
for Daewoong Pharma.

Provide Net Margin
for Daewoong Pharma.

Provide FCF Margin
for Daewoong Pharma.

Show all solvency ratios
for Daewoong Pharma.

Provide D/E Ratio
for Daewoong Pharma.

Provide D/A Ratio
for Daewoong Pharma.

Provide Interest Coverage Ratio
for Daewoong Pharma.

Provide Altman Z-Score Ratio
for Daewoong Pharma.

Provide Quick Ratio
for Daewoong Pharma.

Provide Current Ratio
for Daewoong Pharma.

Provide Cash Ratio
for Daewoong Pharma.

What is the historical Revenue growth
over the last 5 years for Daewoong Pharma?

What is the historical Net Income growth
over the last 5 years for Daewoong Pharma?

What is the current Free Cash Flow
of Daewoong Pharma?

Discuss the annual earnings per share (EPS)
trend over the past five years for Daewoong Pharma.

Daewoong Pharma

Income Statement

Income from Continuing Operations

Daewoong Pharma
Income from Continuing Operations

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

Adjust for Inflation

Daewoong Pharma
Income from Continuing Operations Peer Comparison

Comparables:

000100

326030

128940

000250

068760

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company		Income from Continuing Operations	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Daewoong Pharma KRX:069620	Income from Continuing Operations ₩84.1B	CAGR 3-Years 88%	CAGR 5-Years N/A	CAGR 10-Years 4%
	Yuhan Corp KRX:000100	Income from Continuing Operations ₩145.9B	CAGR 3-Years 9%	CAGR 5-Years 28%	CAGR 10-Years 5%
	SK Biopharmaceuticals Co Ltd KRX:326030	Income from Continuing Operations -₩35.4B	CAGR 3-Years 48%	CAGR 5-Years 24%	CAGR 10-Years N/A
	Hanmi Pharm Co Ltd KRX:128940	Income from Continuing Operations ₩207.2B	CAGR 3-Years 87%	CAGR 5-Years 35%	CAGR 10-Years 15%
S	Sam Chun Dang Pharm Co Ltd KOSDAQ:000250	Income from Continuing Operations ₩723.7m	CAGR 3-Years N/A	CAGR 5-Years -46%	CAGR 10-Years -24%
C	Celltrion Pharm Inc KOSDAQ:068760	Income from Continuing Operations ₩11.5B	CAGR 3-Years -31%	CAGR 5-Years N/A	CAGR 10-Years 10%

What is Daewoong Pharma's Income from Continuing Operations?

Income from Continuing Operations
84.1B KRW

Based on the financial report for Jun 30, 2024, Daewoong Pharma's Income from Continuing Operations amounts to 84.1B KRW.

What is Daewoong Pharma's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
4%

Over the last year, the Income from Continuing Operations growth was 61%. The average annual Income from Continuing Operations growth rates for Daewoong Pharma have been 88% over the past three years , and 4% over the past ten years .

Daewoong Pharma
KRX:069620

Daewoong Pharma
Income from Continuing Operations

Daewoong Pharma
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

See Also

What is Daewoong Pharma's Income from Continuing Operations?

Income from Continuing Operations
84.1B KRW

What is Daewoong Pharma's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
4%

Company

Help

Tools

Stocks

Daewoong Pharma KRX:069620

Daewoong Pharma Income from Continuing Operations

Daewoong Pharma Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis Latest Figures & CAGR of Competitors

See Also

What is Daewoong Pharma's Income from Continuing Operations? Income from Continuing Operations 84.1B KRW

What is Daewoong Pharma's Income from Continuing Operations growth rate? Income from Continuing Operations CAGR 10Y 4%

Company

Help

Tools

Stocks

Daewoong Pharma
KRX:069620

Daewoong Pharma
Income from Continuing Operations

Daewoong Pharma
Income from Continuing Operations Peer Comparison

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

What is Daewoong Pharma's Income from Continuing Operations?

Income from Continuing Operations
84.1B KRW

What is Daewoong Pharma's Income from Continuing Operations growth rate?

Income from Continuing Operations CAGR 10Y
4%